ASX:ACL Australian Clinical Labs (ACL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Australian Clinical Labs Stock (ASX:ACL) 30 days 90 days 365 days Advanced Chart Get ACL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$728.27 millionP/E Ratio30.38Dividend Yield3.28%Price TargetN/AConsensus RatingN/A Company OverviewAustralian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.Read More… Receive ACL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address ACL Stock News HeadlinesAustralian Clinical Labs Limited (ASX:ACL) Shares Could Be 44% Below Their Intrinsic Value EstimateMay 18, 2025 | finance.yahoo.comLeadership Transition at Australian Clinical LabsApril 15, 2025 | tipranks.comVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.May 24, 2025 | Porter & Company (Ad)Australian Clinical Labs Updates Share Buy-Back ProgressApril 2, 2025 | tipranks.comAustralian Clinical Labs Limited (ASX:ACL) is a favorite amongst institutional investors who own 62%March 28, 2025 | finance.yahoo.comAustralian Clinical Labs Sees Change in Substantial HoldersMarch 3, 2025 | tipranks.comAustralian Clinical Labs Issues New Securities to Bolster EquityMarch 2, 2025 | tipranks.comAustralian Clinical Labs' (ASX:ACL) Dividend Will Be A$0.035March 1, 2025 | finance.yahoo.comSee More Headlines ACL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Australian Clinical Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Coles Group (COL). Company Calendar Ex-Dividend for 4/15 Dividend3/26/2025Record date for 4/15 Dividend4/15/2025Dividend Payable4/15/2025Today5/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:ACL CIKN/A Webwww.clinicallabs.com.au Phone61 3 9538 6777FaxN/AEmployees5,115Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.12 Trailing P/E Ratio30.38 Forward P/E RatioN/A P/E Growth-0.36Net Income$23.93 million Net Margins3.45% Pretax MarginN/A Return on Equity13.98% Return on Assets6.67% Debt Debt-to-Equity Ratio174.00 Current Ratio0.64 Quick Ratio0.53 Sales & Book Value Annual Sales$696.37 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares201,830,000Free FloatN/AMarket Cap$728.27 million OptionableNot Optionable Beta1.18 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (ASX:ACL) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Clinical Labs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Clinical Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACL Stock Free ACL Stock Alerts